In the present study, we aimed to validate the prognostic role of DDR1 expression in CRC in a random sample of Egyptian patients and to validate its proposed relation to the Wnt/beta-catenin pathway which was found to be dysregulated in 90% of CRC cases [26]. This evidence concerns the gene DDR1 and colorectal carcinoma.